CXCR3B inhibits the cAMP/PKA signaling pathway to reduce cell migration, and CXCR3 activates the PLC-B/Ca2+ pathway to promote tumor cell dissemination and metastasis, so high expression of CXCR3B suggests a good prognosis. This evidence concerns the gene CXCR3 and neoplasm.